Clozapine N-oxide
Chemical compound
From Wikipedia, the free encyclopedia
Clozapine N-oxide (CNO) is a synthetic drug used mainly in biomedical research as a ligand to activate Designer Receptors Exclusively Activated by Designer Drugs (DREADDs),[1] despite the initial belief that it was biologically inert. However, it has been shown to not enter the brain after administration[2] and to reverse metabolize in peripheral tissues to form clozapine. Clozapine can bind to a number of different serotonergic, dopaminergic and adrenergic receptors within the brain.[3] These off-target effects mean behavioral data using the CNO-DREADD system have to be interpreted with caution.[4]
| Names | |
|---|---|
| IUPAC name
3-chloro-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-11H-benzo[b][1,4]benzodiazepine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.164.243 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C18H19ClN4O | |
| Molar mass | 342.83 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| Danger | |
| H301, H315, H319, H335 | |
| P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Alternatives to CNO with more affinity, more inert character, and faster kinetics include Compound 21 (C21)[5] and deschloroclozapine (DCZ).[6]
